Other languages Trial Holdings Inc.

Equities

141A

JP3635490000

Delayed Japan Exchange Other stock markets 08:54:17 2024-05-08 pm EDT			5-day change	1st Jan Change
2,834 ^JPY	+0.64%		+3.28%	0.00%

May. 06	Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints	MT
May. 06	UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT	May. 06
US Equity Markets Close Higher Friday Following Weak Jobs Report	May. 03
Sector Update: Health Care Stocks Mixed Late Afternoon	May. 03
Sector Update: Health Care	May. 03
Top Midday Decliners	May. 03
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition	May. 03
Google trial wraps up as judge weighs landmark US antitrust claims	May. 03
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	May. 03
AEON Biopharma Shares Slump Pre-Bell After Failed Chronic Migraine Phase 2 Trial	May. 03
Kelso raises stake in NCC; Transense joins project	May. 03
Arrowhead Nets $50 Milestone Payment from Royalty Pharma After Completion of Enrollment in Trial of Cardiovascular Drug	May. 03
Ondine Biomedical shares rise on fundraise to advance Steriwave	May. 03
Ondine Biomedical to Raise GBP3 Million Via Placing, Subscription	May. 03
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	May. 03
Google faces second day of closing arguments in US antitrust trial	May. 03
Amgen Lifts Low-End of Full-Year Revenue Outlook; 'Encouraged' by Interim Data of Potential Obesity Drug	May. 03
Actinogen Medical Raising Up to AU$8.9 Million for Advancing Trial, Working Capital; Shares Fall 24%	May. 02
Abogado de Trump sugiere que pago de dinero a cambio de silencio fue una extorsión	May. 02
US judge questions Google, DOJ in market power trial closing	May. 02
AstraZeneca Says Calquence Combination Improves Progression-Free Survival in Phase 3 Mantle Cell Lymphoma Trial	May. 02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Trial Holdings Inc.

Equities

141A

JP3635490000

Other languages

Filters